rs150415498
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_144672.4(OTOA):c.1522G>A(p.Val508Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00217 in 1,614,006 control chromosomes in the GnomAD database, including 13 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V508A) has been classified as Likely benign.
Frequency
Consequence
NM_144672.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OTOA | NM_144672.4 | c.1522G>A | p.Val508Met | missense_variant | 15/29 | ENST00000646100.2 | NP_653273.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OTOA | ENST00000646100.2 | c.1522G>A | p.Val508Met | missense_variant | 15/29 | NM_144672.4 | ENSP00000496564.2 |
Frequencies
GnomAD3 genomes AF: 0.00188 AC: 286AN: 152036Hom.: 2 Cov.: 32
GnomAD3 exomes AF: 0.00218 AC: 547AN: 251320Hom.: 2 AF XY: 0.00218 AC XY: 296AN XY: 135812
GnomAD4 exome AF: 0.00220 AC: 3218AN: 1461850Hom.: 11 Cov.: 32 AF XY: 0.00220 AC XY: 1599AN XY: 727234
GnomAD4 genome AF: 0.00188 AC: 286AN: 152156Hom.: 2 Cov.: 32 AF XY: 0.00192 AC XY: 143AN XY: 74378
ClinVar
Submissions by phenotype
not provided Benign:3
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | May 01, 2024 | OTOA: BP4, BS2 - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Aug 31, 2018 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Jun 13, 2017 | p.Val508Met in exon 14 of OTOA: This variant is not expected to have clinical si gnificance because it has been identified in 0.6% (150/25792) of Finnish and 0.3 3% (423/126554) European chromosomes including 3 homozygotes by the Genome Aggre gation Database (gnomAD, http://gnomad.broadinstitute.org/; dbSNP rs150415498). - |
OTOA-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jun 05, 2020 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at